Immunotherapy for pediatric brain tumors: past and present.

Neuro Oncol 2019 Oct;21(10):1226-1238

Division of Oncology, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois.

The field of cancer immunotherapy has progressed at an accelerated rate over the past decade. Pediatric brain tumors thus far have presented a formidable challenge for immunotherapy development, given their typically low mutational burden, location behind the blood-brain barrier in a unique tumor microenvironment, and intratumoral heterogeneity. Despite these challenges, recent developments in the field have resulted in exciting preclinical evidence for various immunotherapies and multiple clinical trials. This work reviews the history and advances in active immunotherapy, checkpoint blockade, and adoptive T-cell therapy for pediatric brain tumors, including ongoing clinical trials.

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/noz077DOI Listing
October 2019
1 Read
5.562 Impact Factor

Publication Analysis

Top Keywords

brain tumors
12
pediatric brain
12
clinical trials
8
advances active
4
barrier unique
4
unique tumor
4
tumor microenvironment
4
active immunotherapy
4
microenvironment intratumoral
4
immunotherapy
4
location blood-brain
4
mutational burden
4
low mutational
4
burden location
4
immunotherapy checkpoint
4
history advances
4
blood-brain barrier
4
reviews history
4
trials work
4
exciting preclinical
4

Altmetric Statistics

Similar Publications